1-1 of 1
Kelli L. Running
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Lenalidomide (Len) and Dexamethasone (Dex) in Patients with CD56-Positive Relapsed or Relapsed/Refractory Multiple Myeloma (MM)

Jesus G. Berdeja, MD, Francisco Hernandez-Ilizaliturri, MD, Asher Chanan-Khan, MD, Manish Patel, MD, Kevin R. Kelly, MD, Kelli L. Running, Mary Murphy, Robin Guild, Christina Carrigan, PhD, Sharron Ladd, Beni B. Wolf, MD, PhD, James J. O'Leary, MD, Sikander Ailawadhi, MD
Journal: Blood
Blood (2012) 120 (21): 728.
https://doi.org/10.1182/blood.V120.21.728.728
Published: 2012